Core Viewpoint - The company is strategically investing in Suzhou Changhe Biotechnology Co., Ltd. to acquire a 57.14% stake, aiming to expand its business in the field of biosafety monitoring [2]. Group 1: Investment Strategy - The investment is based on the company's strategic development plan and is a cautious decision to enhance its market position in biosafety monitoring [2]. - The acquisition will allow for deep integration in product technology development, operational production, and sales channels between the company and Changhe Biotechnology [2]. Group 2: Market Position and Product Development - The company is a leading player in the gas sensor industry, with a strong market position in indoor and outdoor air quality sensors, including PM2.5, CO2, VOC, and formaldehyde sensors [2]. - The strategic integration with Changhe Biotechnology will enable the company to expand its sensor industry into high-end biosafety detection instruments [2]. - The company plans to leverage its core component advantages in the sensor field to develop low-cost biosafety sensors for mass applications in home appliances, automotive, and building sectors [2].

Core Viewpoint - Sifang Optoelectronics has signed a strategic investment agreement with Suzhou Changhe Biotechnology, acquiring a 57.14% stake in the company, aiming to expand into the high-end bio-safety detection instrument sector [1] Group 1: Strategic Investment - The investment was made using Sifang Optoelectronics' own funds through the transfer of equity and capital increase [1] - This strategic integration will allow both companies to deeply merge in product technology development, operational production, and sales channels [1] Group 2: Market Expansion - Sifang Optoelectronics plans to leverage its core component advantages in the sensor field to develop low-cost bio-safety sensors [1] - The new bio-safety sensors are intended for mass application in household appliances, automobiles, and buildings [1]